CYPHERPUNK TECHNOLOGIES INC. Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants
CYPHERPUNK TECHNOLOGIES INC. (CYPH) reported Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants of 268.41 thousand shares for the 12-month period ending 2018-12-31, per its 10-K filed 2020-03-16.
Discontinued › Income Statement › Earnings Per Share
us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants · last filed 2020-03-16
- CYPHERPUNK TECHNOLOGIES INC. incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2018-09-30 was 509.93K shares.
- CYPHERPUNK TECHNOLOGIES INC. incremental common shares attributable to dilutive effect of call options and warrants for fiscal 2018 was 268.41K shares, a 903.66% increase from fiscal 2017.
- CYPHERPUNK TECHNOLOGIES INC. incremental common shares attributable to dilutive effect of call options and warrants for fiscal 2017 was 26.74K shares.
| Period end | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 3 month | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 12 month |
|---|---|---|
| 2018-12-31 | 268.41K shares 10-K · filed 2020-03-16 | |
| 2018-09-30 | 509.93K shares 10-Q · filed 2019-11-14 | |
| 2017-12-31 | 26.74K shares 10-K · filed 2019-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |